Get the Flash Player to see this player.
Click here to view our new company videoPower of
Plants
Mankind has for centuries
relied on plants as a valuable source of therapeutic agents to treat disease and maintain good health. Using traditional Chinese medicines (TCM) as a discovery engine and starting point, Phynova develops patent-protected pharmaceuticals, OTC drugs, cosmetic and functional ingredients.
Melokinex™ POI
For Post Operative Ileus
Phytobacx™ MRSA
For MRSA and Acne
PYN17 HEPATITIS C
Chronic Hepatitis C
PYN22 Obesity/NAFLD
For Obesity/Non Alcoholic Fatty Liver Disease ('NAFLD')
PYN18 Antivirals
Hepatitis C Virus and Dengue
THMPs
Multiple indications to be registered under THMP Directive
Relivergen™
Supplement for general liver health
Pipeline
Phynova has identified a number of Drug Candidates in the fields of anti-virals, anti-microbials, gasteroenterology, and anti-inflammatories, as well as developing products for the OTC and Consumer and Personal Healthcare markets.
News
Phynova Announces Start of Clinical Study in Post Operative Ileus in China
21 September 2009 Phynova Group Ltd ("Phynova" or the "Company") PHYNOVA ANNOUNCES ST... More